2021 MIPS Improvement Activity IA_PSPA_6: Consultation of the Prescription Drug Monitoring Program

Activity Description

Clinicians would attest to reviewing the patients’ history of controlled substance prescription using state prescription drug monitoring program (PDMP) data prior to the issuance of a Controlled Substance Schedule II (CSII) opioid prescription lasting longer than 3 days. For the transition year, clinicians would attest to 60 percent review of applicable patient’s history. For the Quality Payment Program Year 2 and future years, clinicians would attest to 75 percent review of applicable patient’s history performance.

Activity ID Activity Weighting Sub-Category Name
IA_PSPA_6 High Patient Safety and Practice Assessment


Anesthesiology-2021, IA_2021, Nephrology-2021